|
MFN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.865400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.278190E-01 |
| Normal-vs-Stage2 |
4.282800E-01 |
| Normal-vs-Stage3 |
5.915500E-02 |
| Normal-vs-Stage4 |
4.617800E-02 |
| Stage1-vs-Stage2 |
9.265800E-01 |
| Stage1-vs-Stage3 |
4.417000E-01 |
| Stage1-vs-Stage4 |
3.828600E-01 |
| Stage2-vs-Stage3 |
5.115400E-01 |
| Stage2-vs-Stage4 |
4.106800E-01 |
| Stage3-vs-Stage4 |
6.951600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.996600E-01 |
| Normal-vs-AfricanAmerican |
1.710960E-01 |
| Normal-vs-Asian |
5.208600E-01 |
| Caucasian-vs-AfricanAmerican |
4.791000E-01 |
| Caucasian-vs-Asian |
8.847000E-01 |
| AfricanAmerican-vs-Asian |
9.393400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.953700E-02 |
| Normal-vs-Female |
5.082800E-01 |
| Male-vs-Female |
1.215720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.835600E-02 |
| Normal-vs-Extreme_Weight |
2.262500E-02 |
| Normal-vs-Obese |
2.348000E-01 |
| Normal-vs-Extreme_Obese |
9.261000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.847800E-01 |
| Normal_Weight-vs-Obese |
3.894600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.680400E-01 |
| Extreme_Weight-vs-Obese |
3.040000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.148000E-01 |
| Obese-vs-Extreme_Obese |
6.847800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.561200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.053600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.298190E-01 |
| Normal-vs-Age(81-100Yrs) |
3.203100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.767200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.097200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.238900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.560160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.076200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.284780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.743600E-01 |
| Normal-VS-Type2 PRCC |
1.506280E-02 |
| Normal-VS-KIRP CIMP |
7.513700E-02 |
| Normal-VS-Unclassified PRCC |
6.817400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.579710E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.417600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.609400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.482800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.839600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.002200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.392400E-04 |
| Normal-vs-N1 |
5.593200E-01 |
| Normal-vs-N2 |
5.837800E-01 |
| N0-vs-N1 |
9.988200E-02 |
| N0-vs-N2 |
9.736200E-01 |
| N1-vs-N2 |
5.020200E-01 |
|
|
